After myocardial infarction in mice, there was an increase in Trem2 expression in macrophages during the subacute phase of cardiac injury. Administering soluble Trem2 in vivo resulted in marked enhancements in both the functional and structural aspects of the infarcted hearts. The gene discussed is TREM2; the disease is myocardial infarction.